Identifying progression-specific genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays.

使用寡核苷酸微阵列识别成人 T 细胞白血病/淋巴瘤的进展特异性基因。

基本信息

  • 批准号:
    13671068
  • 负责人:
  • 金额:
    $ 2.56万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Adult T-cell leukemia/lymphoma (ATL), i.e., peripheral T-lymphocytic malignancy with diverse clinical features, is associated with human T-lymphotropic virus type-1 (HTLV-1). However, the precise mechanism of multi-step leukemogenesis in ATL remains unknown. To understand the change in expression that occur in the progression from chronic phase to acute crisis of ATL, the gene expression profiles of fresh ATL cells were compared in 4 pairs of samples (progression of chronic to acute- phase in 3 patients, and typical chronic phase sample versus typical acute phase sample) using high density oligonucleotide microarrays (HuGeneFL, Affymetrix, Santa Clara, CA). We identified 203 genes that were commonly up-regulated (including ribosomal proteins, proteosome subunits, eukaryotic translation factors, immunophilins, heat shock proteins and genes important for DNA replication, such as helicase) and 91 genes that were commonly down-regulated (including immune molecules and a phosphatase) in the acute phase as compared to chronic phase samples. Several of the genes were previously identified to be associated with the Tax protein of HTLV-1. Some of the up-regulated genes were located in an amplified regions identified as determined by comparative genomic hybridization in the corresponding chronic/acute ATL sample. In contrast, none of the down-regulated genes were located in deleted regions. Using real-time quantitative polymerase chain reaction, we confirmed the microarray-results in those specimens analyzed and observed similar changes in gene expression in 32 additional ATL-specimens. These results demonstrated that a distinct set of genes that are known to be critical in cell transformation and/or activation are modulated during the transition from the chronic to the acute phase of ATL.
成人 T 细胞白血病/淋巴瘤 (ATL),即具有不同临床特征的外周 T 淋巴细胞恶性肿瘤,与人类 T 淋巴细胞病毒 1 型 (HTLV-1) 有关。然而,ATL 多步骤白血病发生的确切机制仍不清楚。为了了解 ATL 从慢性期进展到急性危象过程中发生的表达变化,使用高密度寡核苷酸微阵列(HuGeneFL,Affymetrix,Santa Clara,CA)比较了 4 对样本(3 名患者的慢性期进展为急性期,以及典型慢性期样本与典型急性期样本)中新鲜 ATL 细胞的基因表达谱。与慢性期样本相比,我们鉴定了 203 个在急性期通常上调的基因(包括核糖体蛋白、蛋白体亚基、真核翻译因子、亲免素、热休克蛋白和对 DNA 复制重要的基因,如解旋酶)和 91 个通常下调的基因(包括免疫分子和磷酸酶)。先前已鉴定出其中几个基因与 HTLV-1 的 Tax 蛋白相关。一些上调基因位于通过相应慢性/急性 ATL 样本中的比较基因组杂交确定的扩增区域中。相反,没有一个下调基因位于删除区域。使用实时定量聚合酶链式反应,我们确认了所分析样本中的微阵列结果,并在另外 32 个 ATL 样本中观察到了类似的基因表达变化。这些结果证明,在 ATL 从慢性期向急性期的转变过程中,一组已知对细胞转化和/或激活至关重要的独特基因受到调节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUKASAKI Kunihiro其他文献

TSUKASAKI Kunihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUKASAKI Kunihiro', 18)}}的其他基金

Chromosomal instability in the multi-step carcinogenesis of adult T-cell leukemia/lymphoma
成人 T 细胞白血病/淋巴瘤多步致癌过程中的染色体不稳定性
  • 批准号:
    15591012
  • 财政年份:
    2003
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
  • 批准号:
    81041002
  • 批准年份:
    2010
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目
间变性淋巴瘤激酶基因(Anaplastic Lymphoma Kinase,ALK)功能研究及其小分子抑制剂斑马鱼筛选模型的建立
  • 批准号:
    31000542
  • 批准年份:
    2010
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
结外NK/T细胞淋巴瘤-鼻型异常MicroRNA表达及作用机制研究
  • 批准号:
    81071944
  • 批准年份:
    2010
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

RNA helicases; switched paralogue dependency as an exploitable vulnerability in aggressive B cell lymphoma.
RNA解旋酶;
  • 批准号:
    EP/Y030303/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 2.56万
  • 项目类别:
Optimisation of small molecule inhibitors for effective targeting of phospholipase C gamma in T-cell lymphoma
优化小分子抑制剂以有效靶向 T 细胞淋巴瘤中的磷脂酶 C γ
  • 批准号:
    MR/Y503344/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Research Grant
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
  • 批准号:
    478278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Operating Grants
Implications of cancer cell mechanics in evasion of cellular phagocytosis
癌细胞力学在逃避细胞吞噬作用中的意义
  • 批准号:
    495533
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
  • 批准号:
    23K07830
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Artificial Intelligence analysis of the immune-checkpoint and immuno-oncology in B-cell non-Hodgkin lymphoma
B 细胞非霍奇金淋巴瘤免疫检查点和免疫肿瘤学的人工智能分析
  • 批准号:
    23K06454
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of Novel Therapeutic Targets for Primary Intraocular Malignant Lymphoma Based on Analysis of B Cells within Tertiary Lymphoid Structures
基于三级淋巴结构内 B 细胞的分析阐明原发性眼内恶性淋巴瘤的新治疗靶点
  • 批准号:
    23K15921
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of a simple diagnostic method and novel therapy for improving the prognosis of dog with alimentary lymphoma
开发一种简单的诊断方法和新的疗法来改善患有消化性淋巴瘤的狗的预后
  • 批准号:
    23K14087
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
  • 批准号:
    10648346
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了